Ecofibre reports A$7m loss in FY21 by Martin Lane August 4, 2021August 4, 2021 ASX-listed Ecofibre has reported a A$7m loss in FY21 fuelled by falling sales from its Ananda […]
Company news: Neurotech International; MGC Pharma; Creso Pharma; Zelira Therapeutics; Ecofibre by Martin Lane May 5, 2021May 7, 2021
Your daily dose of cannabis news: Ecofibre’s US acquisition; Zelira Therapeutics requests trading halt; Aussie kids and cannabis by Martin Lane July 30, 2020July 30, 2020